Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

EXPOSOMICS · Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe

FP7Status: CLOSED1 November 201230 April 2017EU funding €8,748,629

This project aims to predict individual disease risk related to the environment, by characterizing the external and internal exposome for common exposures (air and drinking water contaminants) during critical periods of life, including in utero. A large amount of health data is now available from longitudinal cohorts in both children and adults, with detailed information on risk factors, confounders and outcomes, but these are not well linked with environmental exposure data. The exposome concept refers to the totality of environmental exposures from conception onwards, and is a novel approach to studying the role of the environment in human disease. This project will move the field forward by utilising data on individual external exposome (including sensors, smartphones, geo-referencing, satellites), and omic profiles in an agnostic search for new and integrated biomarkers. These tools will be applied in both experimental short-term studies and long-term longitudinal studies in humans. The ultimate goal is to use the new tools in risk assessment and in the estimation of the burden of environmental disease. The involvement of two SMEs, one specialized in sensors and smartphone development, the other in complex data integration, will increase the chances of a successful impact on European Public Health. This multidisciplinary proposal combines:•development of a general framework for the systematic measurement of the internal and external exposome in Europe in relation to air and water contamination, as a way to reduce uncertainty in risk assessment and to address the effects of mixtures and complex exposures;•evaluation of health outcomes and key physiological changes in short-term studies (including a randomized trial) and life-course studies with a large amount of information on diet, physical activity and anthropometry;•evaluation of the burden of disease in the European population, based on state-of-the-art assessment of population exposures.

Consortium · 14 organisations

coordinator

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

UK · €1,246,767

participant

UNIVERSITEIT HASSELT

BE

participant

FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL - CREAL

ES · €1,185,106

participant

FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA

ES

participant

UNIVERSITEIT MAASTRICHT

NL · €1,444,272

participant

GENEDATA AG

CH · €461,380

participant

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT

CH · €482,417

participant

NTRAM GENERAL S.A.

ES · €259,272

participant

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

US · €245,451

participant

UNIVERSITY OF BRISTOL

UK · €77,830

participant

ETHNIKO IDRYMA EREVNON

EL · €222,360

participant

UNIVERSITEIT UTRECHT

NL · €1,361,304

participant

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

FR · €1,130,152

participant

KING'S COLLEGE LONDON

UK · €632,318

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.